Sidelined or streamlined? Diabetic care and COVID-19
December 6, 2021Sales and Marketing
The worldwide restrictions put in place as a result of COVID-19 have necessitated innovation in multiple medical spheres. Diabetes, which …
TIB Molbiol develops test kits for Omicron variant detection
December 6, 2021Sales and Marketing
TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations …
FDA grants Lilly’s COVID-19 antibody therapy EUA for paediatric use
December 6, 2021Sales and Marketing
Eli Lilly has been granted an expanded Emergency Use Authorisation (EUA) for its neutralising antibody treatment, based on the safety …
J&J COVID-19 booster shows increase in antibody and T-cell responses, in Phase II trial
December 6, 2021Sales and Marketing
Johnson & Johnson have announced positive results from an independent Phase II study, which reveal that a booster shot of …
Omicron could become dominant variant in UK within weeks, expert warns
December 6, 2021Research and Development
Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …
UK study shows Pfizer and Moderna jabs give best COVID-19 protection
December 3, 2021Medical Communications
The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …
WHO say Delta measures will help fight Omicron
December 3, 2021Medical Communications
WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …
Researchers develop blood test for HPV-associated head and neck cancer
December 3, 2021Medical Communications
A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …
ARASENS Phase III trial for prostate cancer treatment meets primary endpoint
December 3, 2021Medical Communications
Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …
QIAGEN announces CE marking of T-cell response measuring device
December 2, 2021Business Services
QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …
UK regulator approves antibody drug which may help tackle Omicron
December 2, 2021Research and Development
UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …
EU bring forward launch of COVID-19 vaccine for children
December 1, 2021Research and Development
The rollout of Pfizer and BioNTech’s COVID-19 vaccine version for children aged five to 11 years old will begin on …
UK Health Secretary Javid urges for more COVID-19 tests amid rising Omicron cases and vaccine developments
December 1, 2021Research and Development
Health secretary of the UK, Sajid Javid, has urged the public to take lateral flow tests before attending parties this …
FDA approves new drug for identification of ovarian cancer
November 30, 2021Manufacturing and Production
The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer …
FDA plans fast approvals for Omicron-targeting vaccines
November 30, 2021Manufacturing and Production
Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against …
NICE recommends Tagrisso (osimertinib) in England for lung cancer patients
November 30, 2021Manufacturing and Production
AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …
Vaccine makers pledge to develop Omicron-effective jab
November 29, 2021Sales and Marketing
Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …
Nottinghamshire school sets up targeted testing for Omicron
November 29, 2021Sales and Marketing
A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …
WHO: unclear if Omicron causes severe disease
November 29, 2021Sales and Marketing
WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …
FDA approves AI-based breast cancer screening software MammoScreen®
November 29, 2021Sales and Marketing
The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
